Mochi Health vs Ro: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Mochi Health beats Ro overall, scoring 7.7/10 vs 7.2/10. Ro is more affordable at $149/mo vs $178/mo. Choose Mochi Health for users who want a tech-forward platform with app-based tracki. Choose Ro for users who want fda-approved brand-name glp-1 access includin.

A side-by-side look at Mochi Health and Ro to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Mochi Health

#18 of 52

7.7/10

Tech-forward GLP-1 platform with a sleek app for tracking progress, medications, and provider communications.

Visit Mochi Health

Ro

#43 of 52

7.2/10

One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.

Visit Ro

Feature	Mochi Health	Ro
Our Score	7.7/10	7.2/10
Starting Price	$178/mo	$149/mo
Medication Type	Compounded	Brand
Insurance Accepted	No	Yes
Best For	Users who want a tech-forward platform with app-based tracking	Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing
Ranking	#18	#43
Get started	Visit Mochi Health	Visit Ro

Pros & Cons Compared

Mochi Health

Pros

+Flat $99/mo semaglutide at ALL dose levels, saves $100-200/mo vs competitors who charge more at higher doses
+4 semaglutide formats: injection, oral tablet, oral drops, and microdose, the most delivery options of any platform
+Registered dietitians included alongside physicians, not just medication, but nutritional support
+Both compounded and brand-name medications available (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus)

Cons

−Separate $79/mo membership fee makes the real cost ~$178/mo for semaglutide, not the advertised $99
−No refunds for payments made over 30 days ago, limited consumer protection window
−Relatively new company (founded 2022) with less track record than established platforms

Ro

Pros

+Carries Foundayo (orforglipron), Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026, at $149-299/mo via LillyDirect matching
+Direct insurance billing with major carriers, with coverage, Wegovy or Zepbound can cost $0-25/mo copay
+Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
+Claims matched pricing with LillyDirect, NovoCare, and TrumpRx, some of the lowest cash brand prices available

Cons

−Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
−Brand-name only, no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
−Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)

Our Verdict

Mochi Health edges out Ro with a score of 7.7/10 vs 7.2/10. If budget is your priority, Ro starts at $149/mo compared to Mochi Health's $178/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Mochi Health if you want: users who want a tech-forward platform with app-based tracking. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Mochi Health nor Ro feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review